Aida Pharmaceuticals Stock Performance

AIDA Stock  USD 0.0003  0.00  0.00%   
On a scale of 0 to 100, Aida Pharmaceuticals holds a performance score of 10. The firm shows a Beta (market volatility) of -0.36, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Aida Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Aida Pharmaceuticals is likely to outperform the market. Please check Aida Pharmaceuticals' jensen alpha, rate of daily change, and the relationship between the variance and skewness , to make a quick decision on whether Aida Pharmaceuticals' price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Aida Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Aida Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Aida Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  0.02  in Aida Pharmaceuticals on November 6, 2025 and sell it today you would earn a total of  0.01  from holding Aida Pharmaceuticals or generate 50.0% return on investment over 90 days. Aida Pharmaceuticals is currently generating 0.7937% in daily expected returns and assumes 6.2994% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of pink sheets are less volatile than Aida, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Aida Pharmaceuticals is expected to generate 8.39 times more return on investment than the market. However, the company is 8.39 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Aida Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Aida Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0003 90 days 0.0003 
about 9.12
Based on a normal probability distribution, the odds of Aida Pharmaceuticals to move above the current price in 90 days from now is about 9.12 (This Aida Pharmaceuticals probability density function shows the probability of Aida Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Aida Pharmaceuticals has a beta of -0.36. This suggests as returns on the benchmark increase, returns on holding Aida Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Aida Pharmaceuticals is likely to outperform the market. Additionally Aida Pharmaceuticals has an alpha of 0.7628, implying that it can generate a 0.76 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Aida Pharmaceuticals Price Density   
       Price  

Predictive Modules for Aida Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aida Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aida Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00036.25
Details
Intrinsic
Valuation
LowRealHigh
0.000.00026.25
Details
Naive
Forecast
LowNextHigh
0.0000060.00036.25
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00030.00030.0003
Details

Aida Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Aida Pharmaceuticals is not an exception. The market had few large corrections towards the Aida Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aida Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aida Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.76
β
Beta against Dow Jones-0.36
σ
Overall volatility
0.000048
Ir
Information ratio 0.11

Aida Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aida Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aida Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Aida Pharmaceuticals is way too risky over 90 days horizon
Aida Pharmaceuticals has some characteristics of a very speculative penny stock
Aida Pharmaceuticals appears to be risky and price may revert if volatility continues
Aida Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Aida Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aida Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aida Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aida to invest in growth at high rates of return. When we think about Aida Pharmaceuticals' use of debt, we should always consider it together with cash and equity.

Aida Pharmaceuticals Fundamentals Growth

Aida Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Aida Pharmaceuticals, and Aida Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aida Pink Sheet performance.

About Aida Pharmaceuticals Performance

By analyzing Aida Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Aida Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aida Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aida Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China. Aida Pharmaceuticals is traded on OTC Exchange in the United States.

Things to note about Aida Pharmaceuticals performance evaluation

Checking the ongoing alerts about Aida Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Aida Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Aida Pharmaceuticals is way too risky over 90 days horizon
Aida Pharmaceuticals has some characteristics of a very speculative penny stock
Aida Pharmaceuticals appears to be risky and price may revert if volatility continues
Aida Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Aida Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aida Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aida Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aida to invest in growth at high rates of return. When we think about Aida Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Evaluating Aida Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Aida Pharmaceuticals' pink sheet performance include:
  • Analyzing Aida Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aida Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Aida Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Aida Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aida Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Aida Pharmaceuticals' pink sheet. These opinions can provide insight into Aida Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Aida Pharmaceuticals' pink sheet performance is not an exact science, and many factors can impact Aida Pharmaceuticals' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Aida Pink Sheet analysis

When running Aida Pharmaceuticals' price analysis, check to measure Aida Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aida Pharmaceuticals is operating at the current time. Most of Aida Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aida Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aida Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aida Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios